You are here

Rengasayee Veeraraghavan

  • Assistant Professor, Biomedical Engineering
  • Assistant Professor
  • 333 W. 10th Ave
    Graves Hall
    Columbus, OH 43210



  • B.Tech., Anna University, India, 2005
  • Ph.D., University of Utah, 2011

Key Honors and Distinctions

  • Ranked eleventh among all graduates in the B.Tech, Chemical Engineering Program, Anna University, India. (2005)
  • International Gap Junction Conference Travel Award (2011)
  • Travel Award, Gordon Research Conference on Cardiac Arrhythmia Mechanisms (2013)
  • The Clinical Research Award in Honor of Mark Josephson and Hein Wellens for 2013-14, Heart Rhythm Society (2013)
  • Postdoctoral Research Fellowship for 2013-15, American Heart Association (2013)
  • Best Oral Presentation Award, International Gap Junction Conference (2013)
  • Outstanding Postdoctoral Platform Presentation - Runner Up, Virginia Tech Carilion Research Institute Annual Retreat (2015)
  • Basic Cardiovascular Sciences Travel Grant, American Heart Association Scientific Sessions (2015)
  • George Palade Award for distinguished contributions to the field of microscopy and microanalysis in the life sciences, Microscopy Society of America (2017)
  • Young Investigator Award (Basic Science) from the Cardiac Electrophysiology Society (2017)

RESEARCH AREAS – Veeraraghavan Lab for Biomedical Engineering

  • Bioengineering; Cardiac Arrhythmia Mechanisms; Atrial Fibrillation; Super-resolution Microscopy; Quantitative Image Analysis
  • Graduate student and post-doctoral research opportunities are currently available.


Poelzing S, Veeraraghavan R, Smoot A, X-ray attenuating compositions and methods. U.S. Patent 8808668; filed April 2009.

Dr. Veeraraghavan’s research investigates the fundamental mechanisms of cardiac arrhythmias, atrial fibrillation in particular, using an array of structural and functional imaging tools that span scales from the single molecule to the whole organ. The lab’s research is driven by an engineering approach and aimed at simultaneously elucidating how the heart functions in health and in disease while developing novel peptide drugs to prevent life-threatening cardiac rhythm disturbances. Using this multi-pronged approach, he aims to uncover the mechanisms by which vascular dysfunction (and consequent cardiac edema) alters sodium channel-rich nanodomains within the cardiomyocyte intercalated disk and precipitates arrhythmogenic conduction defects. His work is supported by the American Heart Association.